LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 47 filers reported holding LOGICBIO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $532,000 | -52.7% | 230,121 | -6.3% | 0.02% | -44.1% |
Q3 2021 | $1,124,000 | +1.5% | 245,492 | -1.5% | 0.03% | 0.0% |
Q2 2021 | $1,107,000 | -39.9% | 249,256 | -1.5% | 0.03% | -35.8% |
Q1 2021 | $1,843,000 | -3.4% | 253,102 | +1.2% | 0.05% | -23.2% |
Q4 2020 | $1,908,000 | – | 250,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 500,000 | $2,290,000 | 0.43% |
Orbimed Advisors | 8,466,783 | $38,778,000 | 0.43% |
Sio Capital Management, LLC | 182,630 | $836,000 | 0.27% |
Eversept Partners, LP | 349,919 | $1,602,629 | 0.11% |
SAMLYN CAPITAL, LLC | 1,474,108 | $6,752,000 | 0.09% |
PLATINUM INVESTMENT MANAGEMENT LTD | 320,273 | $1,467,000 | 0.04% |
PURA VIDA INVESTMENTS, LLC | 245,492 | $1,124,000 | 0.03% |
SANDERS MORRIS HARRIS LLC | 35,000 | $160,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 176,500 | $808,000 | 0.02% |
Ergoteles LLC | 65,827 | $301,000 | 0.01% |